<< Back
Mar 22, 2018

Omnicell To Present At Needham & Company's 17th Annual Healthcare Conference

MOUNTAIN VIEW, Calif., March 22, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at Needham & Company's 17th Annual Healthcare Conference at the Westin Grand Central Hotel, New York, NY. 

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

Omnicell Speaker: Peter Kuipers, executive vice president & CFO

Date:Tuesday, March 27, 2018
Time: 1:30 p.m. ET
Location:Westin Grand Central Hotel, New York, NY
Availability: The audio-webcast of the live presentation may be accessed by visiting:
http://ir.omnicell.com/events.cfm

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-E

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/omnicell-to-present-at-needham--companys-17th-annual-healthcare-conference-300618405.html

SOURCE Omnicell, Inc.

Peter Kuipers, Chief Financial Officer, 800-850-6664,peter.kuipers@omnicell.com